MSDS

Material Safety Data Sheet
MSDS Number: 000000002228
Bayer Advanced Dual Action Rose & Flower Insect Killer
Ready-To-Use
MSDS Version 1.0
Page 5 of 7
ACGIH
None
NTP
None
IARC
None
OSHA
None
Reproductive &
Developmental Toxicity
BETA-CYFLUTHRIN TECHNICAL
DEVELOPMENTAL TOXICITY: In an oral developmental toxicity study in rats
treated with beta cyfluthrin, decreased fetal body weights and an increased
incidence of skeletal findings were observed at the maternally toxic and lethal
high dose level (40 mg/kg).
IMIDACLOPRID TECHNICAL
DEVELOPMENTAL TOXICITY: In developmental toxicity studies in rats and
rabbits, there was no evidence of an embryotoxic or teratogenic potential for
imidacloprid. In both species, developmental effects were observed only at high
doses and in conjunction with maternal toxicity.
REPRODUCTION: In a two-generation reproduction study in rats, imidacloprid
was not a primary reproductive toxicant. Offspring exhibited reduced body
weights at the high dose and in conjunction with maternal toxicity.
Neurotoxicity
BETA-CYFLUTHRIN TECHNICAL
In acute and subchronic neurotoxicity screening studies in rats, beta-cyfluthrin
produced slight transient neurobehavioral effects in each study at the highest
dose tested. There were no correlating morphological changes in neural tissues
in either study.
IMIDACLOPRID TECHNICAL
In acute and subchronic neurotoxicity screening studies in rats, imidacloprid
produced slight neurobehavioral effects in each study at the highest dose tested.
There were no correlating morphological changes observed in the neural tissues.
In a one-generation developmental neurotoxicity screening study in rats,
offspring exposed to imidacloprid showed decreased body weights and motor
activities. These effects occurred at the highest dose tested and in conjunction
with maternal toxicity. There were no correlating morphological changes
observed in the neural tissues.
Mutagenicity
BETA-CYFLUTHRIN TECHNICAL
Numerous in vitro and in vivo mutagenicity studies have been conducted on
beta-cyfluthrin, all of which are negative.
IMIDACLOPRID TECHNICAL
The imidacloprid mutagenicity studies, taken collectively, demonstrate that the
active ingredient is not genotoxic or mutagenic.